GlaxoSmithKline Pakistan Limited (PSX:GLAXO)
Pakistan
· Delayed Price · Currency is PKR 409.57
-34.89 (-7.85%)
At close: Apr 25, 2025
GlaxoSmithKline Pakistan Cash Flow Statement
Financials in millions PKR. Fiscal year is January - December.
Millions PKR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | 6,536 | 533.95 | 2,463 | 5,354 | 3,375 | Upgrade
|
| Depreciation & Amortization | 1,136 | 932.3 | 859.38 | 775.27 | 761.5 | Upgrade
|
| Loss (Gain) From Sale of Assets | -21.88 | -82.76 | -124.62 | -633.9 | -17.21 | Upgrade
|
| Asset Writedown & Restructuring Costs | 18.39 | 6.01 | 18.02 | 15.54 | 30.81 | Upgrade
|
| Provision & Write-off of Bad Debts | 1.76 | 160.34 | 89.7 | 42.74 | -30.5 | Upgrade
|
| Other Operating Activities | 1,552 | -703.15 | -431.51 | 1,204 | 679.82 | Upgrade
|
| Change in Accounts Receivable | 471.58 | 395.71 | -358.67 | -154.15 | -37.98 | Upgrade
|
| Change in Inventory | -365.39 | -2,256 | -3,363 | -1,077 | 180.77 | Upgrade
|
| Change in Accounts Payable | -1,009 | 4,332 | 2,827 | -36.69 | 956.95 | Upgrade
|
| Change in Other Net Operating Assets | -3,257 | -1,386 | -5,142 | -512.05 | 30.39 | Upgrade
|
| Operating Cash Flow | 5,058 | 1,884 | -3,161 | 4,987 | 5,960 | Upgrade
|
| Operating Cash Flow Growth | 168.51% | - | - | -16.33% | 132.28% | Upgrade
|
| Capital Expenditures | -2,775 | -1,649 | -1,533 | -1,304 | -1,316 | Upgrade
|
| Sale of Property, Plant & Equipment | 134.32 | 212.95 | 244.47 | 777.27 | 52.99 | Upgrade
|
| Other Investing Activities | 538.91 | 279.45 | 827.1 | 374.94 | 237.1 | Upgrade
|
| Investing Cash Flow | -2,102 | -1,157 | -461.6 | -151.56 | -1,026 | Upgrade
|
| Long-Term Debt Repaid | -51.12 | -25.59 | -14.6 | -11.46 | -12.09 | Upgrade
|
| Net Debt Issued (Repaid) | -51.12 | -25.59 | -14.6 | -11.46 | -12.09 | Upgrade
|
| Common Dividends Paid | -1.76 | -1,845 | -375.03 | -2,062 | -1,892 | Upgrade
|
| Financing Cash Flow | -52.88 | -1,871 | -389.63 | -2,073 | -1,904 | Upgrade
|
| Net Cash Flow | 2,903 | -1,144 | -4,012 | 2,762 | 3,031 | Upgrade
|
| Free Cash Flow | 2,282 | 234.56 | -4,694 | 3,683 | 4,644 | Upgrade
|
| Free Cash Flow Growth | 873.04% | - | - | -20.69% | 279.89% | Upgrade
|
| Free Cash Flow Margin | 3.73% | 0.47% | -11.22% | 10.05% | 13.23% | Upgrade
|
| Free Cash Flow Per Share | 7.17 | 0.74 | -14.74 | 11.57 | 14.58 | Upgrade
|
| Cash Interest Paid | - | - | - | - | 8.86 | Upgrade
|
| Cash Income Tax Paid | 2,698 | 2,309 | 2,639 | 871.59 | 810 | Upgrade
|
| Levered Free Cash Flow | 3,051 | -1,126 | -1,473 | 3,545 | 4,278 | Upgrade
|
| Unlevered Free Cash Flow | 3,063 | -1,122 | -1,470 | 3,549 | 4,282 | Upgrade
|
| Change in Net Working Capital | 1,705 | 1,633 | 3,964 | 218.77 | -1,768 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.